Literature DB >> 3556187

MPTP: insights into the etiology of Parkinson's disease.

J W Langston.   

Abstract

MPTP-induced parkinsonism in humans faithfully replicates the clinical features of Parkinson's disease, including physical findings, response to therapy and even complications of therapy. Further, the neuropathological picture in experimental animals appears to be drawing much closer to that seen in the idiopathic disease, particularly in the light of recent findings showing involvement of the locus ceruleus as well as the substantia nigra, and the presence of eosinophilic inclusion bodies. It is suggested that the more closely the MPTP model comes to reproducing Parkinson's disease, the more valuable it may be in exploring the etiology of the disease. MPTP could provide insights into mechanisms underlying neuronal degeneration in the substantia nigra and other areas of the brain in Parkinson's disease, and has already set in motion a renewed search for possible environmental causes of the disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3556187     DOI: 10.1159/000116349

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  5 in total

1.  Linking selective vulnerability to cell death mechanisms in Parkinson's disease.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

Review 2.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

Review 3.  Behavioral phenotyping of mouse models of Parkinson's disease.

Authors:  Tonya N Taylor; James G Greene; Gary W Miller
Journal:  Behav Brain Res       Date:  2010-03-06       Impact factor: 3.332

Review 4.  Resveratrol as a therapeutic agent for neurodegenerative diseases.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-21       Impact factor: 5.590

Review 5.  Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.

Authors:  Susan Duty; Peter Jenner
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.